SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

FHTX

Foghorn Therapeutics Inc.
NASDAQHealth Care

Latest close: 1.85 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record3359 flagged findings
Reported transactions (Form 4)68since Feb 10, 2022 · and 25 other holdings
Corporate events (8-K)29since Nov 25, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…the fair value of the 7,451,564 Series Warrants to be $ 12.2 million . The key inputs to the valuation model included the weighted…”
    +1 more passage from the same document
    • “…below) below $ 13.42 per share, then the initial exercise price of the Series Warrants will be automatically reset upon…”
  • 2026-03-11share offering or dilution eventrecentOpen filing ↗
    “…price per share of the Common Stock less the $0.0001 exercise price per share of each pre-funded warrant. The offering (the…”
    +1 more passage from the same document
    • “…from the issuance of the pre-funded warrants as additional paid-in capital on the Company’s consolidated balance sheets and…”
  • 2026-03-11Department of Justice inquiryrecentOpen filing ↗
    “…activities of product candidates following product approval, where applicable, or commercialization are also subject to regulation…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 335)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 5, 26Form 3 ↗Insider transaction
  • Oct 5, 26SCHEDULE 13G/A ↗Passive stake · BVF PARTNERS L P/IL · 14.3% · event on Oct 1, 26 · amendment
  • Oct 1, 268-K ↗Current report · Restructuring plan with committed costs
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results · Communication to the market
  • Insider transaction · 9 Form 4 filingsshow all 9hide
  • Jun 24, 268-K ↗Current report · Shareholder vote results
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · BVF PARTNERS L P/IL · 10.0% · event on Mar 31, 26 · amendment
  • May 14, 26SCHEDULE 13G/A ↗Passive stake · Deerfield Mgmt, L.P. · 8.6% · event on Mar 31, 26 · amendment
  • May 7, 2610-Q ↗Quarterly report
  • May 7, 268-K ↗Current report · Results · Communication to the market
  • May 6, 26SCHEDULE 13G/A ↗Passive stake · FMR LLC · 11.6% · event on Mar 31, 26 · amendment
  • Apr 30, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 30, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 21, 268-K ↗Current report · Communication to the market · Other events
  • Apr 13, 26Form 4 ↗Insider transaction
  • Mar 11, 2610-K ↗Annual report

335 filings on record, the oldest from Sep 24, 20.

Listing the 25 most recent filings of the 335 on record.

8-Ks, explained

Stress2Structure13Governance14
  • Oct 1, 26StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Governance3 senior executive changes2025 – 2026show all 3hide
    • Feb 23, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Dec 4, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Nov 5, 25GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Jul 1, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 1, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 24, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Dec 30, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • May 22, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2024show all 3hide
    • Apr 16, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jan 17, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jan 3, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 10, 23StructureA material agreement was terminated8-K 1.02 ↗
  • Governance3 senior executive changes2022show all 3hide
    • Oct 27, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Aug 31, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Aug 17, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 15, 22StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jan 10, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗

7 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Noubar Afeyan27.2%Jan 9, 26SCHEDULE 13D/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BVF PARTNERS L P/IL14.3%Oct 1, 26SCHEDULE 13G/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • FMR LLC11.6%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Deerfield Mgmt, L.P.8.6%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 23, 24Sell$9KCarlos CostaChief People Officer↗
  • Sep 20, 24Sell$359KCarlos CostaChief People Officer↗
  • Sep 18, 24Sell$116KCarlos CostaChief People Officer↗
  • Sep 17, 24Sell$103KCarlos CostaChief People Officer↗
  • Sep 16, 24Sell$4KCarlos CostaChief People Officer↗
  • Sep 9, 24Sell$190KSteven F. BellonChief Scientific Officer↗
  • Mar 11, 24Sell$72KFanny CavalieChief Strategy/Bus Ops Officer↗
  • Aug 16, 23Sell$2.6MSamuel AgrestaChief Medical Officer↗
Stock compensation, tax and giftsshow the 20 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Apr 10, 26Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Apr 9, 26Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Apr 25, 25Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Apr 9, 25Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Sep 23, 24Compensation$3KCarlos CostaChief People Officer↗
  • Sep 20, 24Compensation$133KCarlos CostaChief People Officer↗
  • Sep 18, 24Compensation$43KCarlos CostaChief People Officer↗
  • Sep 17, 24Compensation$38KCarlos CostaChief People Officer↗
  • Sep 16, 24Compensation$1KCarlos CostaChief People Officer↗
  • Aug 17, 23Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Aug 17, 23Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Aug 16, 23Compensation$1.2MSamuel AgrestaChief Medical Officer↗
  • May 26, 23Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Feb 17, 23Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Feb 17, 23Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Feb 17, 23Otheramount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Oct 25, 22Otheramount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Oct 25, 22Otheramount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Feb 10, 22Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗
  • Feb 10, 22Giftamount n/aADRIAN GOTTSCHALKChief Executive Officer↗

The full record holds 28 transactions and goes back to Feb 10, 22.

Its sector and its market

Foghorn Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Foghorn Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Foghorn Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
335 documents on file, from Sep 24, 2020 to Oct 5, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.